Latest Options News

Paradigm Biopharmaceuticals has upsized a $14 million placement and launched a $2 million SPP, boosting its cash runway to around $45 million. This capital injection supports the ongoing Phase 3 trial for knee osteoarthritis, with interim results expected in Q3 2026.

Voltaic Strategic Resources has added a strategic exploration licence adjacent to its Ti Tree Project in Western Australia, consolidating its position along the Yinnetharra lithium corridor. The low-cost acquisition enhances its exposure to lithium and tantalum resources in a highly prospective geological setting.

Albright Metals delivers strong high-grade gold results from its Golden Pike Project in Canada while boosting its balance sheet through a $1.8 million tenement sale to Catalyst Metals, sharpening its focus on high-impact assets.

Corella Resources has agreed to acquire a majority interest in the Chobe Project, expanding its footprint in Western Australia’s emerging rare earths and niobium hotspot. The acquisition is backed by a heavily oversubscribed $5 million capital raise.

Corella Resources has agreed to acquire a majority interest in the Chobe Project, a highly prospective niobium and rare earths ground in Western Australia’s West Arunta, supported by a heavily oversubscribed $5 million capital raise.

Forrestania Resources has reported a series of high-grade gold intercepts from drilling at British Hill, Mt Palmer, and Johnson Range projects in Western Australia, underscoring its methodical exploration approach and potential resource growth.

Chimeric Therapeutics' CHM CORE-NK cell therapy achieved a 60% complete response rate in high-risk frontline AML patients, significantly exceeding typical outcomes and maintaining a strong safety profile.

HITIQ Limited's March quarter saw a remarkable 223% jump in sales to $294k, driven by the nationwide rollout of its PROTEQT™ concussion management system and initial international sales. The company bolstered its governance and advisory ranks while managing funding to support its commercial push.

Barton Gold Holdings has reported exceptional high-grade gold assays up to 170 g/t at its Challenger project and strong drilling progress at Tunkillia, underpinning an advancing feasibility study and a robust cash balance of $13.3 million.

88 Energy has amended its Participation Agreement with Burgundy Xploration, extending funding milestones to align with Burgundy’s US IPO process while securing US$400,000 in near-term payments and enhanced lease security. The Franklin Bluffs-1H well spud is now expected in Q1 2027, slightly delayed but underpinned by strong capital commitment.

Adisyn has confirmed a major graphene breakthrough compatible with semiconductor manufacturing and secured exclusive radar absorption rights, backed by a $14 million placement led by top institutional investors.

Diatreme Resources reported a $745,000 net loss for FY 2025 but strengthened its financial footing through asset sales and an IPO stake. The company’s Northern Silica Project and Cyclone Zircon Project showed significant technical progress, while a major Cape Flattery asset sale aims to streamline operations and unlock funding.